These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 25587085

  • 1. LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a.
    Liang J, Li Y, Daniels G, Sfanos K, De Marzo A, Wei J, Li X, Chen W, Wang J, Zhong X, Melamed J, Zhao J, Lee P.
    Mol Cancer Res; 2015 Apr; 13(4):681-8. PubMed ID: 25587085
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-34a Attenuates Metastasis and Chemoresistance of Bladder Cancer Cells by Targeting the TCF1/LEF1 Axis.
    Liu X, Liu X, Wu Y, Fang Z, Wu Q, Wu C, Hao Y, Yang X, Zhao J, Li J, Wang Q, Yang Z, Xu J, Hu X, Tan M, Li L.
    Cell Physiol Biochem; 2018 Apr; 48(1):87-98. PubMed ID: 30001529
    [Abstract] [Full Text] [Related]

  • 3. MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells.
    Dong P, Xiong Y, Watari H, Hanley SJ, Konno Y, Ihira K, Yamada T, Kudo M, Yue J, Sakuragi N.
    J Exp Clin Cancer Res; 2016 Sep 05; 35(1):132. PubMed ID: 27596137
    [Abstract] [Full Text] [Related]

  • 4. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
    Wang M, Ren D, Guo W, Wang Z, Huang S, Du H, Song L, Peng X.
    Int J Oncol; 2014 Jul 05; 45(1):362-72. PubMed ID: 24805183
    [Abstract] [Full Text] [Related]

  • 5. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
    Huang LX, Hu CY, Jing L, Wang MC, Xu M, Wang J, Wang Y, Nan KJ, Wang SH.
    Cancer Sci; 2017 Oct 05; 108(10):1985-1995. PubMed ID: 28771881
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X, Luo X, Wu Y, Xia D, Chen W, Fang Z, Deng J, Hao Y, Yang X, Zhang T, Zhou L, Wu Y, Wang Q, Xu J, Hu X, Li L.
    Cell Physiol Biochem; 2018 Oct 05; 50(1):261-276. PubMed ID: 30282072
    [Abstract] [Full Text] [Related]

  • 7. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
    Liu DC, Song LL, Liang Q, Hao L, Zhang ZG, Han CH.
    J Cell Physiol; 2019 Aug 05; 234(8):12727-12744. PubMed ID: 30613973
    [Abstract] [Full Text] [Related]

  • 8. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y, Yan W, Zhang W, Chen L, You G, Bao Z, Wang Y, Wang H, Kang C, Jiang T.
    Oncol Rep; 2012 Sep 05; 28(3):1013-21. PubMed ID: 22766851
    [Abstract] [Full Text] [Related]

  • 9. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X, Du H, Song L, Peng X.
    Cell Tissue Res; 2014 Dec 05; 358(3):763-78. PubMed ID: 25296715
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S, Wei C, Cheng J, Khan MA, Fu S, Yang L, Tania M, Zhang X, Xiao X, Zhang X, Fu J.
    Oncotarget; 2017 Mar 28; 8(13):21362-21379. PubMed ID: 28423483
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-381 inhibits metastasis and epithelial-mesenchymal transition of glioblastoma cells through targeting LEF1.
    Min RQ, Ma Q.
    Eur Rev Med Pharmacol Sci; 2020 Jun 28; 24(12):6825-6833. PubMed ID: 32633375
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, Li G, Lu X, Sun Z, Tang KF.
    Carcinogenesis; 2012 Mar 28; 33(3):519-28. PubMed ID: 22198213
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway.
    Liang X, Li H, Fu D, Chong T, Wang Z, Li Z.
    Biochem Biophys Res Commun; 2016 Nov 11; 480(2):208-214. PubMed ID: 27746178
    [Abstract] [Full Text] [Related]

  • 20. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T, Ito M.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):114-9. PubMed ID: 18834855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.